108
Views
12
CrossRef citations to date
0
Altmetric
Articles

SUCCESSFUL USE OF TERBUTALINE IN PERSISTENT PRIAPISM IN A 12-YEAR-OLD BOY WITH CHRONIC MYELOID LEUKEMIA

, MD, DM, , MD & , DGO
Pages 70-73 | Received 10 Jun 2007, Accepted 18 Jul 2008, Published online: 09 Jul 2009

REFERENCES

  • Schreibman SM, Gee TS, Grabstald H. Management of priapism in patients with chronic granulocytic leukemia. J Urol. 1974; 111: 786–788
  • Vilke GM, Harrigan RA, Ufberg JW, Chan TC. Emergency evaluation and treatment of priapism. J Emerg Med. 2004; 26: 325–329
  • Morano SG, Latagliata R, Carmosino I, Girmenia C, Dal Forno S, Alimena G. Treatment of long-lasting priapism in chronic myeloid leukemia at onset. Ann Hematol 2000; 79: 644–645
  • Becker HC, Pralle H, Weidner W. Therapy of priapism in high counting myeloid leukemia—A combined oncological–urological approach: Two case reports. Urol Int 1985; 40: 284–286
  • Ponniah A, Brown C, Taylor P. Priapism secondary to leukemia: Effective management with prompt leukapheresis. Int J Urol 2004; 11: 809
  • Ghalaut PS, Kalra GS, Gupta S. Priapism: A rare presentation in chronic myeloid leukaemia. J Assoc Physicians India 1996; 44: 354–355
  • Shantha TR, Finnerty DP, Rodriquez AP. Treatment of persistent penile erection and priapism using terbutaline. J Urol. 1989; 141: 1427–1429
  • Priyadarshi S. Oral terbutaline in the management of pharmacologically induced prolonged erection. Int J Impot Res. 2004; 16: 424–426

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.